Alcidion Group Ltd banner

Alcidion Group Ltd
ASX:ALC

Watchlist Manager
Alcidion Group Ltd Logo
Alcidion Group Ltd
ASX:ALC
Watchlist
Price: 0.105 AUD -4.55% Market Closed
Market Cap: AU$141m

Alcidion Group Ltd
Investor Relations

Alcidion Group Ltd. provides intelligent health informatics technology that empowers healthcare professionals with clinical decision support systems to ensure the quality of care for the patients. The company is headquartered in Melbourne, Victoria. The company went IPO on 2011-06-24. The company is engaged in development, licensing and reselling its healthcare software products through its strategic partners. The company also delivers product implementation, product support and maintenance, systems integration and data analysis services to healthcare customers in Australia, New Zealand and the United Kingdom. The Company’s healthcare software products include Miya, Patientrack, Smartpage and ExtraMed. Miya Precision is a clinical solution based on a FHIR-event platform that facilitates multiple clinical and operational applications. Smartpage is a smartphone and Web-based system for hospital communication and task management provides solution to both clinical and non-clinical users. Patientrack is a solution that supports the capture of that data at the bedside, whether directly entered on a tablet or integrated from patient monitors. Its clinical solutions use digital technology.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q2 2026
Call Date
Jan 14, 2026
AI Summary
Q2 2026

Contract Wins: Alcidion secured significant new contracts and expansions in Q2, including a $12.3 million contract expansion with Leidos (Australian Defense Force) and being named preferred provider for a $35 million+ contract with University Hospital Sussex (UHSX) in the UK.

Revenue Backlog: The company ended Q2 with $43.1 million of contracted revenue for FY '26, up 40% from last year and already 6% higher than full FY '25 revenue, excluding any Sussex contribution.

Cash Position: Alcidion reported $8.5 million in Q2 cash receipts, a $1.9 million operating cash outflow (due to timing), and closed the quarter with $14.2 million in cash and no debt.

Guidance & Outlook: Management expects FY '26 EBITDA and operating cash flow to be at least in line with FY '25, with possible upside from Sussex and other new deals. They continue to expect stronger cash receipts in the second half.

AI and Product Innovation: Alcidion continues to develop and deploy new AI-powered modules within the Miya Precision platform and is actively supporting healthcare organizations in using AI safely and effectively.

International Expansion: The company is exploring opportunities in Canada and the Middle East, with ongoing market assessments and partnership discussions.

Key Financials
Contracted Revenue
$43.1 million
New Sales (Total Contract Value)
$15.4 million
Leidos Contract Expansion (TCV)
$12.3 million
Annual Recurring Revenue (JP2060/Leidos contract)
In excess of $5.5 million
Cash Receipts from Customers
$8.5 million
Operating Cash Outflow
$1.9 million
Cash Balance
$14.2 million
Debtors Ledger (end Q2)
$10.7 million
Staff Cost Increase
3.7%
NPAT (FY '25)
$1.7 million
UHS Sussex Contract (expected TCV)
At least $35 million
Earnings Call Recording
Other Earnings Calls

Management

Ms. Kate Quirke
Group MD, CEO & Executive Director
No Bio Available
Mr. Matthew Gepp
Chief Financial Officer
No Bio Available
Ms. Julia Stevens
Chief Operating Officer
No Bio Available
Mr. Vivek Krishnan
Chief Technology Officer
No Bio Available
Kerstin Wahlqvist
Investor Relations Manager
No Bio Available
Ms. Maria Hunter
Group General Counsel
No Bio Available
Mr. Nick White
Chief Marketing Officer
No Bio Available
Ms. Tracey Harvey
Human Resources Manager
No Bio Available
Ms. Kaye Hocking
Chief Product Officer
No Bio Available
Ms. Amanda James
Chief People Officer
No Bio Available

Contacts

Address
VICTORIA
Melbourne
L 10 9 Yarra Street, South Yarra
Contacts
+61800767873.0
www.alcidion.com